Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,756.00
Bid: 1,700.00
Ask: 1,779.00
Change: 0.00 (0.00%)
Spread: 79.00 (4.647%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,756.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET CLOSE: FTSE 100 down ahead of US interest rate decision

Wed, 01st May 2024 16:56

(Alliance News) - Stock prices in London closed mostly in the red on Wednesday, as investors eye the latest interest rate decision from the US Federal Reserve this evening.

The FTSE 100 index closed down 22.89 points, 0.3%, at 8,121.24. The FTSE 250 ended down 38.80 points, 0.2%, at 19,926.59, and the AIM All-Share closed up 4.24 points, 0.6%, at 764.98.

The Cboe UK 100 ended down 0.3% at 811.07, the Cboe UK 250 closed down 0.4% at 17,230.04, and the Cboe Small Companies ended up 0.2% at 15,762.48.

Financial markets in Paris and Frankfurt are closed on Wednesday.

The Fed announces its latest interest rate decision at 1900 BST. A press conference with Chair Jerome Powell follows half an hour later.

"It's decision day on interest rates in the US and while the Federal Reserve is almost certain to stick with the status quo, there will be considerable interest in the accompanying commentary. Will markets have to get used to the idea of zero cuts in 2024, having started the year with hopes for rates to be materially lowered?" said AJ Bell's Russ Mould.

Before the Fed decision, there has been a flurry of US data.

The US private sector added more jobs than expected last month, numbers from payroll firm ADP showed.

According to the latest ADP tracker, private employers added 192,000 jobs in April, rising from 184,000 in March. The March reading was downwardly revised from an initially reported 208,000. The latest reading beat the FXStreet cited consensus of 175,000.

The US manufacturing sector was stable in April, purchasing managers' index survey results from S&P Global confirmed on Wednesday, but data from the Institute for Supply Management showed the sector fell into contraction.

The S&P Global US manufacturing PMI posted in line with the 50.0 no-change mark in April to point to stable business conditions at the start of the second quarter. The reading was down from 51.9 in March and signalled an end to a three-month sequence of improving operating conditions.

The ISM PMI reported that economic activity in the manufacturing sector contracted in April after one month of expansion following 16 consecutive months of contraction.

The ISM PMI for manufacturing reading slipped to 49.2 points in April from 50.3 in March.

Stocks in New York were mixed at the London equities close. The DJIA was up 0.2%, though the S&P 500 index and Nasdaq Composite were down 0.4% and 0.5%, respectively.

The pound was quoted at USD1.2487 at the London equities close Wednesday, down compared to USD1.2523 at the close on Tuesday. The euro stood at USD1.0679 at the European equities close Wednesday, lower against USD1.0690 at the same time on Tuesday.

Against the yen, the dollar was trading at JPY157.72, up compared to JPY157.44 late Tuesday.

In the FTSE 100, Haleon lost 3.1%.

The Surrey, England-based consumer health arm, spun out of GSK PLC, backed its annual guidance and reported a "solid" quarter.

Revenue declined 2.2% on-year to GBP2.92 billion in the three months that ended March 31, as revenue for Haleon's Pain Relief and Respiratory Health units fell amid a weaker Covid season in China compared to a year ago.

Cost of sales were reduced by 5.7% to GBP1.08 billion from GBP1.15 billion, helping pretax profit to grow by 8.9% to GBP590 million from GBP542 million.

On the other hand, GSK rose 1.6%.

The London-based pharmaceutical maker said revenue in the first-quarter of the year was up 5.9% to GBP7.36 billion from GBP6.95 billion a year prior.

Pretax profit, however, weakened 29% to GBP1.36 billion from GBP1.91 billion.

In the FTSE 250, Aston Martin lost 6.8%, after a disappointing trading update.

The company reported 945 vehicle sales in the first quarter, down 26% from 1,269 a year before.

Pretax loss widened 87% to GBP138.8 million from GBP74.2 million.

Executive Chair Lawrence Stroll said: "2024 is a year of immense product transformation at Aston Martin, with the introduction of four new models to the market before the end of the year. Our first quarter performance reflects this expected period of transition, as we ceased production and delivery of our outgoing core models ahead of the ramp up in production of the new Vantage, upgraded DBX707 and our upcoming V12 flagship sports car which we've confirmed today. As part of our ongoing programme of ultra-exclusive models, we will deliver a new Special in the fourth quarter of the year."

On AIM, Trinity Exploration & Production rose 53%. Touchstone Exploration shares fell 4.5%.

Touchstone Exploration said it reached an agreement to buy Trinity Exploration & Production.

The Trinidad & Tobago-focused oil exploration and production companies aim to become "a leading Trinidadian operator of scale," according to Touchstone, which calls itself the largest independent onshore oil and natural gas producer in Trinidad.

The all-share agreement values Trinity at GBP24.1 million.

Brent oil was quoted at USD83.78 a barrel at the London equities close Wednesday, down from USD86.42 late Tuesday.

Gold was quoted at USD2,308.30 an ounce at the London equities close Wednesday, up against USD2,298.10 at the close on Tuesday.

In Thursday's UK corporate calendar, has first quarter results from Endeavour Mining, Shell, and Standard Chartered.

The economic calendar for Thursday has manufacturing PMIs from Germany and the eurozone. At 1330 BST, there is the weekly US initial jobless claims, as well as trade balance data.

By Sophie Rose, Alliance News senior reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2024 Alliance News Ltd. All Rights Reserved.

More News
21 May 2024 11:23

AstraZeneca aims for $80 bln in total revenue by 2030

Sees $80 bln in 2030 revenue by 2030

*

Read more
21 May 2024 08:49

GSK's depemokimab asthma treatment meets endpoints in latest trials

(Alliance News) - GSK PLC on Tuesday announced positive results from trials of depemokimab, an "ultra-long-acting biologic" that could simplify treatment options for patients with severe asthma.

Read more
21 May 2024 07:21

GSK reports promising results from asthma treatment trials

(Sharecast News) - GSK announced promising results from phase three clinical trials evaluating the efficacy and safety of depemokimab in treating severe asthma with type 2 inflammation on Tuesday.

Read more
20 May 2024 16:11

IN BRIEF: GSK executive buys GBP20,026 worth shares

GSK PLC - London-based pharmaceuticals firm - Senior Vice President, Global Communications & Chief Executive Office, Sally Jackson, buys 1,120 shares at 1,788 pence each. Worth total GBP20,026.

Read more
17 May 2024 17:38

London's FTSE nudges lower for week after record run

Haleon falls after GSK offloads remaining stake

*

Read more
17 May 2024 15:52

London close: Stocks recoup some earlier losses

(Sharecast News) - London stocks remained in negative territory by Friday's close, although they managed to recoup some of the losses seen earlier in the session as Wall Street opened with positive momentum.

Read more
17 May 2024 11:52

LONDON MARKET MIDDAY: FTSE 100 slides; Eurozone inflation steady

(Alliance News) - Stock prices in London were lacklustre at midday on Friday, as investors eye the trajectory of interest rates across the globe.

Read more
17 May 2024 09:03

TOP NEWS: GSK sells remaining Haleon stake for GBP1.25 billion

(Alliance News) - GSK PLC on Friday said it has sold its remaining shares in Haleon PLC, marking a total exit from its consumer healthcare spin-off.

Read more
17 May 2024 08:56

LONDON MARKET OPEN: FTSE 100 lacklustre as Wall Street rally ends

(Alliance News) - Stock prices in London opened lower on Friday, after Thursday saw Wall Street's rally end in a record breaking session.

Read more
17 May 2024 08:39

GSK raises $1.5 bln from sale of remaining Haleon stake

May 17 (Reuters) - British drugmaker GSK has raised 1.25 billion pounds ($1.52 billion) from a sale of its remaining stake in consumer healthcare company Haleon to institutional investors.

Read more
17 May 2024 07:42

LONDON BRIEFING: Land Securities ups dividend; GSK sells Haleon stake

(Alliance News) - Stocks in London are called to open lower, as investors wait for an inflation reading from the eurozone later this morning.

Read more
17 May 2024 07:29

GSK raises £1.25bn from sale of remaining Haleon stake

(Sharecast News) - GSK said on Friday that it has sold its remaining 4.2% stake in consumer health business Haleon, which it spun off in July 2022.

Read more
16 May 2024 17:33

FTSE 100 ends lower on disappointing corporate updates, BT Group soars

BT Group up after CEO aims for more than double free cash flow

*

Read more
16 May 2024 17:13

TOP NEWS: GSK to sell remaining holding in spin-off Haleon

(Alliance News) - GSK PLC on Thursday said it intends to sell its remaining stake in Haleon PLC, the consumer healthcare firm it spun out almost two years ago.

Read more
16 May 2024 17:02

GSK to sell entire 4.2% remaining stake in Haleon

(Sharecast News) - GSK said on Thursday that it plans to sell its entire remaining 4.2% stake in Haleon.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.